Eli Lilly

News

Graphic of faceless person with board in front of them reading Coming Soon on orange background

UK watchdog takes first action on oral weight drug adverts

Online pharmacies operating in the UK breached Advertising Standards Authority rules by promoting oral weight drugs to the public.

News

Lilly's BTK drug Jaypirca joins first-line options in US

Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA for its first frontline indication, but will it be reserved for later-line use?

News

Woman holds a pill between index finger and thumb

New Lilly combo tops tirzepatide for weight loss in diabetes

Eli Lilly's bid to dominate the next generation of weight-loss therapies has been strengthened by data on its new combination therapy EloraTZP.

News

Lilly fleshes out triple G data in diabetes and obesity

Eli Lilly has revealed more data with its triple G agonist retatrutide, boosting its credentials as the next big thing in cardiometabolic diseases.

News

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik, setting up a market tussle with Novo's recently launched Awiqli.

News

InnoCare and Eli Lilly logos over a handshake graphic in the background

Lilly forges $3.35bn alliance with China's InnoCare

Eli Lilly continues a busy period of deal-making with a five-project partnership with InnoCare that includes $100m in upfront and near-term payments.

UK watchdog takes first action on oral weight drug adverts

Lilly's BTK drug Jaypirca joins first-line options in US

New Lilly combo tops tirzepatide for weight loss in diabetes

Lilly fleshes out triple G data in diabetes and obesity

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

Lilly forges $3.35bn alliance with China's InnoCare

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

Eli Lilly

Editor's Picks